RESUMO
Objective:To explore the Papillary thyroid carcinoma(PTC) in patients with the expression of BRAF protein and correlation with clinical indicators.Methods:During the selection from June 2015 to June 2016 in our hospital diagnosis and treatment of 120 patients with PTC as the observation group,the other choice during the same period in our hospital make a diagnosis and give treatment of PCT 57 cases as control group,patients with thyroid cancer by immunohistochemical method to detect mutated BRAF protein expression in two groups of patients,and analyze the BRAF protein positive expression and the correlation of PTC clinical indicators.Results:Observation group of patients BRAF protein positive rate was 74.17％,the negative rate was 25.83％,control group patients BRAF protein positive rate was 7.02％,the negative rate was 92.98％,the comparison between groups have significant statistical difference(P＜0.01);Age≤45 years,diameter of tumor＞1 cm,TNM staging for Ⅲ ～Ⅳ stage of PTC patients of BRAF protein positive rate were 96.43％,82.35％,95.65％,significantly higher than the age＞45 years,tumor diameter＜1cm,TNM staging for Ⅰ ～ Ⅱ stage were 67.39％,63.46％,69.07％,and the corresponding comparison have significant statistical difference(P＜0.05).Conclusion:PTC mutated BRAF protein positive rate was significantly higher in patients with non PTC thyroid cancer patients,patients with PTC BRAF protein positive expression related to age,tumor diameter and tumor stage.
